Hexagon Bio: Funding, Investors & Team (Sep 2026)
A data-driven biopharma business called Hexagon Bio is creating focused small molecule therapies. To find powerful, evolutionarily-refined small compounds and their corresponding targets directly from DNA sequences, our proprietary platform combines data science, genomics, synthetic biology, chemistry, and automation. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs
Hexagon Bio has raised $253M across 4 funding rounds on record, the most recent a Series B of $77.3M announced in Feb 2023.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Hexagon Bio Company Profile and Key Stats
Latest funding round on record: Feb 2023.
Hexagon Bio Funding Rounds
Hexagon Bio raised $47.0M in an undisclosed round announced in Sep 2020.
1 years later, a Series B of $61.0M was announced in Sep 2021.
1.1 years later, an undisclosed round of $67.3M was announced in Oct 2022.
4 months later, a Series B of $77.3M was announced in Feb 2023.
Hexagon Bio Founders and Leadership Team
Contact details for the Hexagon Bio team: 1 of 2 have an email address on file.
Start 14-day free trial →Hexagon Bio Funding Compared to Other Biotechnology Startups
Hexagon Bio's latest round of $77.3M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Hexagon Bio in Biotechnology and Menlo Park
Companies Similar to Hexagon Bio
SeqWell’s is a biotechnology company that specializes in the fields of gene sequencing and laboratory…
DermaSensor’s mission is to save lives and healthcare costs by providing easy access to effective skin cancer…
Solstice Oncology is a clinical stage immuno-oncology company
Encoded Therapeutics is a developer of precision gene therapies intended to provide treatment for a broad…
BrainChild Bio is a biotechnology company in the clinical stage that specializes in pediatric brain tumors.…
Superluminal Medicines is a biotech company that specializes in rapidly developing new drugs through a…
Senticell's mission is to fully harness the unique immune and genetic functions of RBC to transform and treat…
ImmunoPhotonics, Inc. develops immunotherapy-based treatments for cancer. ImmunoPhotonics, Inc. has a…
EIT Pharma is a commercial-stage biotechnology company focuses on developing and commercializing…
Halia Therapeutics is a biopharmaceutical company in the preclinical stage that is developing new treatments…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Hexagon Bio Funding FAQs
What does Hexagon Bio do?
A data-driven biopharma business called Hexagon Bio is creating focused small molecule therapies. To find powerful, evolutionarily-refined small compounds and their corresponding targets directly from DNA sequences, our proprietary platform combines data science, genomics, synthetic biology, chemistry, and automation. We are mining fungal genomes for inspiration for the next generation of targeted therapies for diseases with unmet needs
How much funding has Hexagon Bio raised?
Hexagon Bio has raised $253M across 4 rounds on record. The most recent is a Series B of $77.3M announced in Feb 2023.
When did Hexagon Bio last raise funding?
Hexagon Bio's most recent funding round on record is a Series B of $77.3M, announced in Feb 2023.
Who founded Hexagon Bio?
FundedIQ lists Brian Naughton (Founder) at Hexagon Bio.
Who is the CEO of Hexagon Bio?
Maureen Hillenmeyer is listed as CEO at Hexagon Bio.
Where is Hexagon Bio headquartered?
Hexagon Bio is based in Menlo Park, California, United States.
How many employees does Hexagon Bio have?
Hexagon Bio is in the 51-100 employee band.
How does Hexagon Bio's funding compare to other Biotechnology startups?
Hexagon Bio's latest round of $77.3M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,183 tracked companies over the last two years.
About FundedIQ's Hexagon Bio Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Hexagon Bio is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.